Title: Glutamate receptor-mediated inhibition of L-glutamate efflux from cerebral cortex in vitro.
Journal: Brain research 20061009
Title: NXY-059: a hopeful sign in the treatment of stroke.
Journal: Stroke 20061001
Title: Comparison of the neuroprotective effect of clomethiazole, AR-R15896AR and NXY-059 in a primate model of stroke using histological and behavioural measures.
Journal: Brain research 20030516
Title: Assessment of cognitive and motor deficits in a marmoset model of stroke.
Journal: ILAR journal 20030101
Title: Effect of low-affinity NMDA receptor antagonists on electrical activity in mouse cortical slices.
Journal: European journal of pharmacology 20020517
Title: Treatment of acute ischaemic stroke with the low-affinity, use-dependent NMDA antagonist AR-R15896AR. A safety and tolerability study.
Journal: Journal of neurology 20020501
Title: Differential effects of remacemide and desglycinyl-remacemide on epileptiform burst firing in the rat hippocampal slice.
Journal: Neuroscience letters 20020315
Title: A study of the mechanisms involved in the neurotoxic action of 3,4-methylenedioxymethamphetamine (MDMA, 'ecstasy') on dopamine neurones in mouse brain.
Journal: British journal of pharmacology 20011201
Title: Structural modifications to an N-methyl-D-aspartate receptor antagonist result in large differences in trapping block.
Journal: The Journal of pharmacology and experimental therapeutics 20010601
Title: On the relationship between plasma concentrations of drugs and outcome of stroke studies in laboratory animals.
Journal: Annals of the New York Academy of Sciences 20010601
Title: Tolerability of the low-affinity, use-dependent NMDA antagonist AR-R15896AR in stroke patients: a dose-ranging study.
Journal: Stroke 20010201
Title: Sanacora G, et al. Lanicemine: a low-trapping NMDA channel blocker produces sustained antidepressant efficacywith minimal psychotomimetic adverse effects. Mol Psychiatry. 2014 Sep;19(9):978-85.
